European Consensus on the Management of Sensitized Kidney Transplant Recipients: A Delphi Study
Transplant International · 2024
DOI: 10.3389/ti.2024.12475 ↗Kurz gefasst
Editorial in der Zeitschrift Transplant International, 2024. Verfasst von Lucrezia Furian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Kidney and Pancreas Transplantation Unit, Department of Surgical, Oncological and Gastroenterological Sciences, School of Medicine and Surgery, Unive…. Hauptthemen laut MEDLINE: Kidney Transplantation, Delphi Technique, Graft Rejection, Consensus. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
An increasing number of sensitized patients awaiting transplantation face limited options, leading to fatalities during dialysis and higher costs. The absence of established evidence highlights the need for collaborative consensus. Donor-specific antibodies (DSA)-triggered antibody-mediated rejection (AMR) significantly contributes to kidney graft failure, especially in sensitized patients. The European Society for Organ Transplantation (ESOT) launched the ENGAGE initiative, categorizing sensitized candidates by AMR risk to improve patient care. A systematic review assessed induction and maintenance regimens as well as antibody removal strategies, with statements subjected to the Delphi methodology. A Likert-scale survey was distributed to 53 European experts (Nephrologists, Transplant surgeons and Immunologists) with experience in kidney transplant recipient care. A rate ≥75% with the same answer was considered consensus. Consensus was achieved in 95.3% of statements. While most recommendations aligned, two statements related to complement inhibitors for AMR prophylaxis lacked consensus. The ENGAGE consensus presents contemporary recommendations for desensitization and immunomodulation strategies, grounded in predefined risk categories. The adoption of tailored, patient-specific measures is anticipated to streamline the care of sensitized recipients undergoing renal allografts. While this approach holds the promise of enhancing transplant accessibility and fostering long-term success in transplantation outcomes, its efficacy will need to be assessed through dedicated studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kidney and Pancreas Transplantation Unit, Department of Surgical, Oncological and Gastroenterological Sciences, School of Medicine and Surgery, University of Padua, Padua, Italy.
- Kidney Transplant Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
- Department of Nephrology and Medical Intensive Care, Charité University Medicine Berlin, Berlin, Germany.
- Transplant Immunology Unit, Department of Cardiac, Thoracic and Vascular Sciences, School of Medicine and Surgery, University of Padua, Padua, Italy.
- Experimental Nephrology and Transplant Laboratory, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
- King's College London, London, United Kingdom.
Zitieren
APA
Furian, L., Bestard, O., Budde, K., Cozzi, E., Diekmann, F., Mamode, N., Naesens, M., Pengel, L. H. M., Schwartz Sorensen, S., Vistoli, F., & Thaunat, O. (2024). European Consensus on the Management of Sensitized Kidney Transplant Recipients: A Delphi Study. Transplant International. https://doi.org/10.3389/ti.2024.12475
Vancouver
Furian L, Bestard O, Budde K, Cozzi E, Diekmann F, Mamode N, et al. European Consensus on the Management of Sensitized Kidney Transplant Recipients: A Delphi Study. Transplant International. 2024. doi:10.3389/ti.2024.12475
BibTeX
@article{Furian2024,
author = {Furian, Lucrezia and Bestard, Oriol and Budde, Klemens and Cozzi, Emanuele and Diekmann, Fritz and Mamode, Nizam and Naesens, Maarten and Pengel, Liset H M and Schwartz Sorensen, Soren and Vistoli, Fabio and Thaunat, Olivier},
title = {European Consensus on the Management of Sensitized Kidney Transplant Recipients: A Delphi Study},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.12475}
}
EUVIMED